Koki Kato

1.6k total citations
30 papers, 1.1k citations indexed

About

Koki Kato is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrine and Autonomic Systems. According to data from OpenAlex, Koki Kato has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 7 papers in Endocrine and Autonomic Systems. Recurrent topics in Koki Kato's work include Neuroscience and Neuropharmacology Research (7 papers), Receptor Mechanisms and Signaling (6 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Koki Kato is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Receptor Mechanisms and Signaling (6 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Koki Kato collaborates with scholars based in Japan and United States. Koki Kato's co-authors include Masaomi Miyamoto, Keisuke Hirai, Osamu Uchikawa, Shuji Hinuma, Shigenori Ohkawa, K. Fukatsu, Keiji Nishiyama, Yuji Kawamata, Yuji Ishihara and Hideomi Fukuda and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Life Sciences.

In The Last Decade

Koki Kato

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koki Kato Japan 17 430 407 286 227 159 30 1.1k
Tonya C. Murphy United States 17 408 0.9× 646 1.6× 655 2.3× 249 1.1× 170 1.1× 23 1.3k
Jean‐Paul Nicolas France 22 355 0.8× 834 2.0× 929 3.2× 174 0.8× 43 0.3× 30 1.8k
Mauro Corsi Italy 26 413 1.0× 864 2.1× 1.2k 4.2× 595 2.6× 195 1.2× 65 2.2k
H.E. Howell France 9 961 2.2× 238 0.6× 335 1.2× 178 0.8× 69 0.4× 13 1.2k
M. L. Dubocovich United States 14 1.1k 2.4× 573 1.4× 693 2.4× 204 0.9× 53 0.3× 15 1.7k
Rod A. Porter United Kingdom 16 900 2.1× 238 0.6× 279 1.0× 949 4.2× 645 4.1× 25 1.6k
Toshiharu Shimazaki Japan 17 236 0.5× 390 1.0× 728 2.5× 151 0.7× 23 0.1× 31 1.2k
Brian Lord United States 31 540 1.3× 949 2.3× 612 2.1× 514 2.3× 403 2.5× 65 2.6k
Vicky Holland United Kingdom 11 144 0.3× 369 0.9× 584 2.0× 156 0.7× 71 0.4× 13 988
George M. Ling Canada 22 144 0.3× 401 1.0× 433 1.5× 241 1.1× 65 0.4× 67 1.3k

Countries citing papers authored by Koki Kato

Since Specialization
Citations

This map shows the geographic impact of Koki Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koki Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koki Kato more than expected).

Fields of papers citing papers by Koki Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koki Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koki Kato. The network helps show where Koki Kato may publish in the future.

Co-authorship network of co-authors of Koki Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Koki Kato. A scholar is included among the top collaborators of Koki Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koki Kato. Koki Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saito, Katsuya, et al.. (2022). A rare case of sacral epidural arteriovenous fistula with concomitant occult multiple lumbar epidural arteriovenous fistulas. Journal of Cerebrovascular and Endovascular Neurosurgery. 25(3). 322–332. 1 indexed citations
2.
Kato, Koki, Akiko Kobayashi, Hiroya Kondo, et al.. (2020). Overexpression of SARS-CoV-2 protein ORF6 dislocates RAE1 and NUP98 from the nuclear pore complex. Biochemical and Biophysical Research Communications. 536. 59–66. 54 indexed citations
3.
Nishiyama, Keiji, Hisao Nishikawa, Koki Kato, et al.. (2014). Pharmacological Characterization of M-II, the Major Human Metabolite of Ramelteon. Pharmacology. 93(3-4). 197–201. 9 indexed citations
4.
Imaeda, Toshihiro, Toshio Tanaka, Masahiro Kamaura, et al.. (2012). Melanin-Concentrating Hormone Receptor 1 Antagonists. Synthesis and Structure–Activity Relationships of Novel 3-(Aminomethyl)quinolines. Journal of Medicinal Chemistry. 55(5). 2353–2366. 27 indexed citations
5.
Imaeda, Toshihiro, Toshio Tanaka, Jun Terauchi, et al.. (2011). Discovery, synthesis, and structure–activity relationship of 6-aminomethyl-7,8-dihydronaphthalenes as human melanin-concentrating hormone receptor 1 antagonists. Bioorganic & Medicinal Chemistry. 19(18). 5539–5552. 9 indexed citations
6.
Kamaura, Masahiro, Kazuyoshi Aso, Kaoru Watanabe, et al.. (2011). Melanin-concentrating hormone receptor 1 antagonists: Synthesis, structure–activity relationship, docking studies, and biological evaluation of 2,3,4,5-tetrahydro-1H-3-benzazepine derivatives. Bioorganic & Medicinal Chemistry. 19(21). 6261–6273. 13 indexed citations
7.
Aicher, Thomas D., Yvan Le Huérou, Stephen S. Gonzales, et al.. (2010). Novel acyl coenzyme A (CoA): Diacylglycerol acyltransferase-1 inhibitors: Synthesis and biological activities of diacylethylenediamine derivatives. Bioorganic & Medicinal Chemistry. 18(7). 2785–2795. 20 indexed citations
8.
Yamamoto, Toshihiro, Hiroshi Yamaguchi, Hiroshi Miki, et al.. (2010). Coenzyme A: Diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets. European Journal of Pharmacology. 640(1-3). 243–249. 25 indexed citations
9.
Yamamoto, Toshihiro, Hiroshi Yamaguchi, Hiroshi Miki, et al.. (2010). A novel coenzyme A:diacylglycerol acyltransferase 1 inhibitor stimulates lipid metabolism in muscle and lowers weight in animal models of obesity. European Journal of Pharmacology. 650(2-3). 663–672. 16 indexed citations
10.
Kato, Koki, Keisuke Hirai, Keiji Nishiyama, et al.. (2004). Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology. 48(2). 301–310. 304 indexed citations
11.
Kato, Koki, et al.. (2003). Changes in glycated haemoglobin levels in diabetic rats measured with an automatic affinity HPLC. Clinical and Experimental Pharmacology and Physiology. 30(10). 752–758. 9 indexed citations
12.
Takekawa, Shiro, Yuji Ishihara, Jun Terauchi, et al.. (2002). T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. European Journal of Pharmacology. 438(3). 129–135. 161 indexed citations
13.
Kato, Koki, et al.. (1999). TAK-147, an acetylcholinesterase inhibitor, increases choline acetyltransferase activity in cultured rat septal cholinergic neurons. Neuroscience Letters. 260(1). 5–8. 84 indexed citations
14.
Hirai, Keisuke, et al.. (1998). Idebenone protects hippocampal neurons against amyloid β-peptide-induced neurotoxicity in rat primary cultures. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(5). 582–585. 26 indexed citations
15.
Ohta, Hiroyuki, et al.. (1996). Relationship of impaired brain glucose metabolism to learning deficit in the senescence-accelerated mouse. Neuroscience Letters. 217(1). 37–40. 20 indexed citations
16.
Kakihana, Mitsuru, et al.. (1993). Detailed characterization of the biological activities of recombinant human nerve growth factor expressed in Chinese hamster ovary cells. Molecular and Chemical Neuropathology. 18(1-2). 51–83. 6 indexed citations
17.
Miyamoto, Masaomi, Keisuke Hirai, Hideki Takahashi, et al.. (1993). Effects of sustained release formation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents. European Journal of Pharmacology. 238(2-3). 181–189. 17 indexed citations
18.
Yamazaki, Naoki, et al.. (1991). Cholinergic drugs reverse AF64A-induced impairment of passive avoidance learning in rats. Psychopharmacology. 103(2). 215–222. 37 indexed citations
19.
Kaisho, Yoshihiko, et al.. (1991). Regional expression of the nerve growth factor gene family in rat brain during development. Biochemical and Biophysical Research Communications. 174(1). 379–385. 37 indexed citations
20.
Kato, Koki, Masayoshi Goto, & Hideomi Fukuda. (1982). Baclofen: Inhibition of the release of l-[3H]glutamate and l-[3H]aspartate from rat whole brain synaptosomes. General Pharmacology The Vascular System. 13(5). 445–447. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tonya C. Murphy Breakdown of academic impact, for papers by Jean‐Paul Nicolas Breakdown of academic impact, for papers by Mauro Corsi Breakdown of academic impact, for papers by H.E. Howell Breakdown of academic impact, for papers by M. L. Dubocovich Breakdown of academic impact, for papers by Rod A. Porter Breakdown of academic impact, for papers by Toshiharu Shimazaki Breakdown of academic impact, for papers by Brian Lord Breakdown of academic impact, for papers by Vicky Holland Breakdown of academic impact, for papers by George M. Ling
Rankless by CCL
2026